ANNA CALLON: Open Payments
NPI 1790474013 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 14 payments from 6 companies in 2025. Trend: 2023 $172 · 2024 $772 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $139 |
| Alkermes, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: UZEDY, ARISTADA, CAPLYTA, ABILIFY MAINTENA, INVEGA SUSTENNA, Qelbree.
Industry payments across KS — which companies pay providers there.
